Tag: mrna
-

Moderna Surprises Wall Street With a Profit and aStronger Outlook
Moderna gave investors something to cheer about with a profit Wall Street wasn’t expecting and a stronger sales outlook.
-

2 Dividend Stocks to Watch as Flu Season Gets Underway
Any investor holding pharmacy and flu-related, coughing-sniffling remedy stocks will tell you that flu season is one of the best times of the year.
-

Pfizer’s Personalized Medicine Strategy Looks Ready to Pay Off
For investors looking to play the personalized medicine theme, Pfizer offers a diversified pipeline, an oncology franchise, and a dividend yield near 6%.
-

Merck and Moderna’s Cancer Vaccine Shows Substantial Promise
Moderna and Merck’s personalized cancer vaccine shows promising melanoma results, potentially opening a new era of targeted cancer treatment.
-

A Hantavirus Outbreak Boosting Moderna (MRNA) Stock? Don’t Bet on It.
Of course, you can do whatever you want with your money but the evidence points to the latest spike in MRNA stock being a reactionary move.